← back to search

Chitra Hosing

The University of Texas MD Anderson Cancer Center · US
🔎 Find collaborators in Hematology · Pathology and Forensic Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, and Multiple Myeloma Research and Treatments.
h-index
72
citations
21,879
works
876
NIH funding
primary concept
Medicine
email

Recent publications

Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.
2025cited by 1position: contributordoi
Supplementary Data 1 from Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma
2025cited by 0position: contributordoi
Data from Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma
2025cited by 0position: contributordoi
Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability.
2022cited by 5position: contributordoi
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD
Bone Marrow Transplantation 2021cited by 23position: middledoi
Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and Usability (Preprint)
2021cited by 0position: contributordoi
A Phase 1 Study of NKX101, an Allogeneic CAR Natural Killer (NK) Cell Therapy, in Subjects with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-Risk Myelodysplastic Syndrome (MDS)
Blood 2020cited by 32position: middledoi
Epstein - Barr virus specific cytotoxic T lymphocytes for the treatment of severe epstein-barr virus mucocutaneous ulcer.
2020cited by 1position: contributordoi
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial
The Lancet Haematology 2019cited by 102position: middledoi
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
New England Journal of Medicine 2018cited by 579position: middledoi
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion
Blood 2018cited by 30position: middledoi
Vigorous exercise mobilizes CD34+ hematopoietic stem cells to peripheral blood via the β2-adrenergic receptor
Brain Behavior and Immunity 2017cited by 53position: middledoi
Better allele-level matching improves transplant-related mortality after double cord blood transplantation
Haematologica 2015cited by 34position: middledoi
Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections
Blood 2014cited by 152position: middledoi
P053
Human Immunology 2014cited by 0position: middledoi
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
Blood 2013cited by 504position: middledoi
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations
Biology of Blood and Marrow Transplantation 2013cited by 400position: middledoi
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
Leukemia 2013cited by 204position: middledoi
Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections
Journal of Antimicrobial Chemotherapy 2013cited by 153position: middledoi
Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial
The Journal of Rheumatology 2013cited by 79position: middledoi
Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture
New England Journal of Medicine 2012cited by 474position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elizabeth J. Shpall · Scripps MD Anderson Cancer Center7 papers (2013–2025) · 6 papers (2020–2025)Amin Alousi · Baylor College of Medicine5 papers (2021–2025)Richard E. Champlin · Baylor College of Medicine5 papers (2021–2025)Uday Popat · The University of Texas MD Anderson Cancer Center5 papers (2021–2025)Richard E. Champlin · The University of Texas MD Anderson Cancer Center5 papers (2013–2021)Uday Popat · The University of Texas MD Anderson Cancer Center3 papers (2013–2021)Betül Oran · The University of Texas MD Anderson Cancer Center3 papers (2014–2021)Y. Nieto · The University of Texas Health Science Center at Houston3 papers (2025–2025)Uday R. Popat · City of Hope3 papers (2025–2025)Terri L Shigle · The University of Texas MD Anderson Cancer Center3 papers (2025–2025)Roland L. Bassett · Scripps MD Anderson Cancer Center3 papers (2025–2025)Samer A. Srour · University of Houston3 papers (2025–2025) · 3 papers (2025–2025)Jeremy Ramdial · University of Pennsylvania3 papers (2025–2025)Alison M. Gulbis · The University of Texas MD Anderson Cancer Center3 papers (2025–2025)Benigno Valdez · The University of Texas MD Anderson Cancer Center3 papers (2025–2025)Muzaffar Qazilbash · Baylor College of Medicine3 papers (2025–2025) · 3 papers (2025–2025)Borje Andersson · The University of Texas MD Anderson Cancer Center3 papers (2025–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hematology · Pathology and Forensic Medicine →